• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性扩张型肥厚型心肌病家系中的突变:一例病例报告及文献复习

mutation in a pedigree with familial dilated hypertrophic cardiomyopathy: A case report and review of literature.

作者信息

Hong Ying, Fan Zhen, Guo Yi, Ma Hui-Hui, Zeng Sheng-Zhi, Xi Hu-Tao, Yang Jing, Luo Kai, Luo Rong, Li Xiao-Ping

机构信息

Department of Cardiology, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China.

Department of Geriatrics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan Province, China.

出版信息

World J Clin Cases. 2025 May 26;13(15):101272. doi: 10.12998/wjcc.v13.i15.101272.

DOI:10.12998/wjcc.v13.i15.101272
PMID:40420933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755214/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) is one of the most prevalent inherited myocardial disorders and is characterized by considerable genetic and phenotypic heterogeneity. A subset of patients with HCM progress to a dilated phase of HCM (DPHCM), which is associated with a poor prognosis; however, the underlying pathogenesis remains inadequately understood.

CASE SUMMARY

In this study, we present a case involving a pedigree with familial DPHCM and conduct a retrospective review of patients with DPHCM with identified gene mutations. Through panel sequencing targeting the coding regions of 312 genes associated with inherited cardiomyopathy, a heterozygous missense mutation (c.746G>A, p.Arg249Glu) in the gene was identified in the proband (III-5). Sanger sequencing subsequently confirmed this pathogenic mutation in three additional family members (II-4, III-4, and IV-3). A total of 26 well-documented patients with DPHCM were identified in the literature. Patients with DPHCM are commonly middle-aged and male. The mean age of patients with DPHCM was 53.43 ± 12.79 years. Heart failure, dyspnoea, and atrial fibrillation were the most prevalent symptoms observed, accompanied by an average left ventricular end-diastolic size of 58.62 mm.

CONCLUSION

Our findings corroborate the pathogenicity of the (c.746G>A, p.Arg249Glu) mutation for DPHCM and suggest that the Arg249Gln mutation may be responsible for high mortality.

摘要

背景

肥厚型心肌病(HCM)是最常见的遗传性心肌疾病之一,其特征是具有显著的遗传和表型异质性。一部分HCM患者会进展为肥厚型心肌病的扩张期(DPHCM),这与预后不良相关;然而,其潜在发病机制仍未得到充分了解。

病例摘要

在本研究中,我们报告了一例涉及家族性DPHCM家系的病例,并对已鉴定出基因突变的DPHCM患者进行了回顾性分析。通过针对与遗传性心肌病相关的312个基因编码区的panel测序,在先证者(III-5)中鉴定出该基因的一个杂合错义突变(c.746G>A,p.Arg249Glu)。随后,Sanger测序在另外三名家庭成员(II-4、III-4和IV-3)中证实了这一致病突变。在文献中总共鉴定出26例有充分记录的DPHCM患者。DPHCM患者通常为中年男性。DPHCM患者的平均年龄为53.43±12.79岁。心力衰竭、呼吸困难和心房颤动是最常见的症状,平均左心室舒张末期内径为58.62mm。

结论

我们的研究结果证实了(c.746G>A,p.Arg249Glu)突变对DPHCM的致病性,并表明Arg249Gln突变可能是高死亡率的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/ca9e8ed0132e/101272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/34aed3e520d2/101272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/d5e88475b71d/101272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/e53d759006ad/101272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/36b9af121a1d/101272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/ca9e8ed0132e/101272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/34aed3e520d2/101272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/d5e88475b71d/101272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/e53d759006ad/101272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/36b9af121a1d/101272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcda/11755214/ca9e8ed0132e/101272-g005.jpg

相似文献

1
mutation in a pedigree with familial dilated hypertrophic cardiomyopathy: A case report and review of literature.家族性扩张型肥厚型心肌病家系中的突变:一例病例报告及文献复习
World J Clin Cases. 2025 May 26;13(15):101272. doi: 10.12998/wjcc.v13.i15.101272.
2
[Gene screening and phenotype analysis in a pedigree with familial hypertrophic cardiomyopathy from Yunnan Province].[云南省一个家族性肥厚型心肌病家系的基因筛查与表型分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Nov 24;46(11):887-891. doi: 10.3760/cma.j.issn.0253-3758.2018.11.013.
3
Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy.全外显子组测序揭示了家族性肥厚型心肌病三种不同表型中的MYH7基因p.R671C突变。
Exp Ther Med. 2021 Sep;22(3):1002. doi: 10.3892/etm.2021.10434. Epub 2021 Jul 15.
4
Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.通过使用Ion Torrent PGM系统的靶向测序方法,在遗传性心肌病患者中鉴定包括双突变在内的新型突变。
Int J Mol Med. 2016 Jun;37(6):1511-20. doi: 10.3892/ijmm.2016.2565. Epub 2016 Apr 14.
5
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.肥厚型心肌病临床表型的遗传决定因素。
BMC Cardiovasc Disord. 2020 Dec 9;20(1):516. doi: 10.1186/s12872-020-01807-4.
6
Dual LQT1 and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1, MYH7, MYLK2, and TMEM70 genes in a three-generation Chinese family.三代中国家系中 KCNQ1、MYH7、MYLK2 和 TMEM70 基因四联体杂合突变与 LQT1 和 HCM 表型相关。
Europace. 2016 Apr;18(4):602-9. doi: 10.1093/europace/euv043. Epub 2015 Mar 29.
7
Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.单等位基因双 MYH7 突变致家族性肥厚型心肌病的遗传学分析。
Mol Med Rep. 2019 Dec;20(6):5229-5238. doi: 10.3892/mmr.2019.10754. Epub 2019 Oct 16.
8
MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.在中国一个肥厚型心肌病家族中鉴定出的与MYH7基因相关的p.V878L突变
Int Heart J. 2019 Nov 30;60(6):1415-1420. doi: 10.1536/ihj.19-146. Epub 2019 Nov 15.
9
Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.两个具有不同心脏β-肌球蛋白重链基因突变的南非家族中家族性肥厚型心肌病的临床及预后评估
Br Heart J. 1995 Jul;74(1):40-6. doi: 10.1136/hrt.74.1.40.
10
Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.肥厚型心肌病合并晚期充血性心力衰竭中线粒体DNA与β-肌球蛋白重链突变共存。
Heart. 1998 Dec;80(6):548-58. doi: 10.1136/hrt.80.6.548.

本文引用的文献

1
Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy.肥厚型心肌病左心室射血分数降低及进展至扩张期的预测因素
J Clin Med. 2023 Aug 5;12(15):5137. doi: 10.3390/jcm12155137.
2
Identification of a novel splicing-altering LAMP2 variant in a Chinese family with Danon disease.在中国一个 Danon 病家系中鉴定到一种新型剪接变异的 LAMP2 基因。
ESC Heart Fail. 2023 Aug;10(4):2479-2486. doi: 10.1002/ehf2.14417. Epub 2023 Jun 5.
3
Contractile pericarditis-like hemodynamics in dilated-phase hypertrophic cardiomyopathy with giant atrium.
扩张期肥厚型心肌病合并巨大心房时类似缩窄性心包炎的血流动力学表现
J Cardiol Cases. 2023 Feb 9;27(5):199-202. doi: 10.1016/j.jccase.2023.01.005. eCollection 2023 May.
4
Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China.基于中国 2190 万人群的队列研究,肥厚型心肌病的患病率、发病率和死亡率。
Sci Rep. 2022 Nov 5;12(1):18799. doi: 10.1038/s41598-022-20042-9.
5
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies.《日本循环学会/日本心力衰竭学会2018年心肌病诊断与治疗指南》
Circ J. 2021 Aug 25;85(9):1590-1689. doi: 10.1253/circj.CJ-20-0910. Epub 2021 Jul 22.
6
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.肥厚型心肌病伴左心室收缩功能障碍:来自 SHaRe 注册研究的见解。
Circulation. 2020 Apr 28;141(17):1371-1383. doi: 10.1161/CIRCULATIONAHA.119.044366. Epub 2020 Mar 31.
7
Vacuolated cardiomyocytes in human endomyocardial biopsy specimens.人类心内膜心肌活检标本中的空泡化心肌细胞。
J Cardiol Cases. 2019 Oct 7;21(2):54-58. doi: 10.1016/j.jccase.2019.09.012. eCollection 2020 Feb.
8
Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.单等位基因双 MYH7 突变致家族性肥厚型心肌病的遗传学分析。
Mol Med Rep. 2019 Dec;20(6):5229-5238. doi: 10.3892/mmr.2019.10754. Epub 2019 Oct 16.
9
Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.肥厚型心肌病扩张期的发病率、临床特征及长期预后
Keio J Med. 2019 Dec 25;68(4):87-94. doi: 10.2302/kjm.2018-0004-OA. Epub 2018 Dec 29.
10
Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.扩张型肥厚型心肌病患者心脏再同步治疗的临床结局
J Geriatr Cardiol. 2017 Apr;14(4):238-244. doi: 10.11909/j.issn.1671-5411.2017.04.002.